The AbN of CD4+ CD25+ CD152+ Tregs in the patients with good and poor pathological tumour responses to 8 cycles of NAC showed significant reductions in circulating levels after chemotherapy, compared with pre-treatment levels, (p = 0.020, p = 0.010, respectively). This evidence concerns the gene CD4 and neoplasm.